Free Trial
ASX:PTX

Prescient Therapeutics (PTX) Stock Price, News & Analysis

Prescient Therapeutics logo

About Prescient Therapeutics Stock (ASX:PTX)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
537,831 shs
Average Volume
N/A
Market Capitalization
A$38.66 million
P/E Ratio
N/A
Dividend Yield
5.88%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Prescient Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

PTX Stock News Headlines

Banks aren’t ready for this altcoin—are you?
The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket change.
See More Headlines

PTX Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Prescient Therapeutics investors own include NOVONIX (NVX), SkyCity Entertainment Group (SKC), KLA (KLAC), Findi (FND) and Chalice Mining (CHN).

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
ASX:PTX
CIK
N/A
Fax
N/A
Employees
171
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$8.24 million
Net Margins
-221.91%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
A$3.71 million
Price / Cash Flow
1.91
Book Value
A$0.02 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
A$38.66 million
Optionable
Not Optionable
Beta
1.19
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (ASX:PTX) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners